 NEW YORK, Aug. 10, 2021 GLOBE NEWSWIRE -- Delcath Systems, Inc. Nasdaq: DCTH, an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today reported business highlights and financial results for the second quarter ended June 30, 2021. 